Search

everythinglearnresearchcommunity

for

Search:↓

Targeting CXCL12 may help treat hair loss caused by androgens.

Androgens may block hair growth signals, targeting this could treat hair loss.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

DHT stops hair regrowth in mice, similar to human hair loss.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Early onset hair loss linked to genetics and androgen levels.

Excess androgens may cause PCOS, not just be a symptom.